129 related articles for article (PubMed ID: 24357936)
1. Inhibition of the early asthmatic response to inhaled allergen by the 5-lipoxygenase activating protein inhibitor GSK2190915: a dose-response study.
Singh D; Boyce M; Norris V; Kent SE; Bentley JH
Int J Gen Med; 2013; 6():897-903. PubMed ID: 24357936
[TBL] [Abstract][Full Text] [Related]
2. The 5-lipoxygenase-activating protein inhibitor, GSK2190915, attenuates the early and late responses to inhaled allergen in mild asthma.
Kent SE; Boyce M; Diamant Z; Singh D; O'Connor BJ; Saggu PS; Norris V
Clin Exp Allergy; 2013 Feb; 43(2):177-86. PubMed ID: 23331559
[TBL] [Abstract][Full Text] [Related]
3. Efficacy, safety and tolerability of GSK2190915, a 5-lipoxygenase activating protein inhibitor, in adults and adolescents with persistent asthma: a randomised dose-ranging study.
Follows RM; Snowise NG; Ho SY; Ambery CL; Smart K; McQuade BA
Respir Res; 2013 May; 14(1):54. PubMed ID: 23682661
[TBL] [Abstract][Full Text] [Related]
4. Attenuation of early and late phase allergen-induced bronchoconstriction in asthmatic subjects by a 5-lipoxygenase activating protein antagonist, BAYx 1005.
Hamilton AL; Watson RM; Wyile G; O'Byrne PM
Thorax; 1997 Apr; 52(4):348-54. PubMed ID: 9196518
[TBL] [Abstract][Full Text] [Related]
5. The effect of GSK2190915, a 5-lipoxygenase-activating protein inhibitor, on exercise-induced bronchoconstriction.
Kent SE; Bentley JH; Miller D; Sterling R; Menendez R; Tarpay M; Pearlman DS; Norris V
Allergy Asthma Proc; 2014; 35(2):126-33. PubMed ID: 24717789
[TBL] [Abstract][Full Text] [Related]
6. The effect of MK-0591, a novel 5-lipoxygenase activating protein inhibitor, on leukotriene biosynthesis and allergen-induced airway responses in asthmatic subjects in vivo.
Diamant Z; Timmers MC; van der Veen H; Friedman BS; De Smet M; Depré M; Hilliard D; Bel EH; Sterk PJ
J Allergy Clin Immunol; 1995 Jan; 95(1 Pt 1):42-51. PubMed ID: 7822663
[TBL] [Abstract][Full Text] [Related]
7. Addition of a 5-lipoxygenase-activating protein inhibitor to an inhaled corticosteroid (ICS) or an ICS/long-acting beta-2-agonist combination in subjects with asthma.
Snowise NG; Clements D; Ho SY; Follows RM
Curr Med Res Opin; 2013 Dec; 29(12):1663-74. PubMed ID: 24010736
[TBL] [Abstract][Full Text] [Related]
8. Pharmacodynamics, pharmacokinetics and safety of GSK2190915, a novel oral anti-inflammatory 5-lipoxygenase-activating protein inhibitor.
Bain G; King CD; Schaab K; Rewolinski M; Norris V; Ambery C; Bentley J; Yamada M; Santini AM; van de Wetering de Rooij J; Stock N; Zunic J; Hutchinson JH; Evans JF
Br J Clin Pharmacol; 2013 Mar; 75(3):779-90. PubMed ID: 22803688
[TBL] [Abstract][Full Text] [Related]
9. Effect of the 5-lipoxygenase inhibitor ZD2138 on allergen-induced early and late asthmatic responses.
Nasser SM; Bell GS; Hawksworth RJ; Spruce KE; MacMillan R; Williams AJ; Lee TH; Arm JP
Thorax; 1994 Aug; 49(8):743-8. PubMed ID: 8091317
[TBL] [Abstract][Full Text] [Related]
10. Effects of a FLAP inhibitor, GSK2190915, in asthmatics with high sputum neutrophils.
Chaudhuri R; Norris V; Kelly K; Zhu CQ; Ambery C; Lafferty J; Cameron E; Thomson NC
Pulm Pharmacol Ther; 2014 Feb; 27(1):62-9. PubMed ID: 24333186
[TBL] [Abstract][Full Text] [Related]
11. Effect of a 5-lipoxygenase inhibitor on leukotriene generation and airway responses after allergen challenge in asthmatic patients.
Hui KP; Taylor IK; Taylor GW; Rubin P; Kesterson J; Barnes NC; Barnes PJ
Thorax; 1991 Mar; 46(3):184-9. PubMed ID: 1851340
[TBL] [Abstract][Full Text] [Related]
12. Differential effects of fluticasone and montelukast on allergen-induced asthma.
Palmqvist M; Bruce C; Sjöstrand M; Arvidsson P; Lötvall J
Allergy; 2005 Jan; 60(1):65-70. PubMed ID: 15575933
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of allergen-induced airway obstruction and leukotriene generation in atopic asthmatic subjects by the leukotriene biosynthesis inhibitor BAYx 1005.
Dahlén B; Kumlin M; Ihre E; Zetterström O; Dahlén SE
Thorax; 1997 Apr; 52(4):342-7. PubMed ID: 9196517
[TBL] [Abstract][Full Text] [Related]
14. The effect of an inhaled leukotriene antagonist, L-648,051, on early and late asthmatic reactions and subsequent increase in airway responsiveness in man.
Bel EH; Timmers MC; Dijkman JH; Stahl EG; Sterk PJ
J Allergy Clin Immunol; 1990 Jun; 85(6):1067-75. PubMed ID: 2191993
[TBL] [Abstract][Full Text] [Related]
15. Pranlukast, a cysteinyl leukotriene receptor antagonist, attenuates allergen-induced early- and late-phase bronchoconstriction and airway hyperresponsiveness in asthmatic subjects.
Hamilton A; Faiferman I; Stober P; Watson RM; O'Byrne PM
J Allergy Clin Immunol; 1998 Aug; 102(2):177-83. PubMed ID: 9723658
[TBL] [Abstract][Full Text] [Related]
16. Effects of JNJ-40929837, a leukotriene A4 hydrolase inhibitor, in a bronchial allergen challenge model of asthma.
Barchuk W; Lambert J; Fuhr R; Jiang JZ; Bertelsen K; Fourie A; Liu X; Silkoff PE; Barnathan ES; Thurmond R
Pulm Pharmacol Ther; 2014 Oct; 29(1):15-23. PubMed ID: 25018015
[TBL] [Abstract][Full Text] [Related]
17. The effect of montelukast (MK-0476), a cysteinyl leukotriene receptor antagonist, on allergen-induced airway responses and sputum cell counts in asthma.
Diamant Z; Grootendorst DC; Veselic-Charvat M; Timmers MC; De Smet M; Leff JA; Seidenberg BC; Zwinderman AH; Peszek I; Sterk PJ
Clin Exp Allergy; 1999 Jan; 29(1):42-51. PubMed ID: 10051701
[TBL] [Abstract][Full Text] [Related]
18. Allergen-induced early and late asthmatic responses are not affected by inhibition of endogenous nitric oxide.
Taylor DA; McGrath JL; O'Connor BJ; Barnes PJ
Am J Respir Crit Care Med; 1998 Jul; 158(1):99-106. PubMed ID: 9655713
[TBL] [Abstract][Full Text] [Related]
19. Effect of the platelet-activating factor antagonist UK-74,505 on the early and late response to allergen.
Kuitert LM; Hui KP; Uthayarkumar S; Burke W; Newland AC; Uden S; Barnes NC
Am Rev Respir Dis; 1993 Jan; 147(1):82-6. PubMed ID: 8420437
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of single-dose inhaled corticosteroid activity with an allergen challenge model.
Kidney JC; Boulet LP; Hargreave FE; Deschesnes F; Swystun VA; O'Byrne PM; Choudry N; Morris MM; Jennings B; Andersson N; Andreasson A; Cockcroft DW
J Allergy Clin Immunol; 1997 Jul; 100(1):65-70. PubMed ID: 9257789
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
